NCT06757738View on ClinicalTrials.gov

A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

January 13, 2025

Study Completion Date

January 31, 2025

Conditions
Healthy Volunteer Study
Interventions
DRUG

TRX-100

CEN inhibitor, dosage form - capsules, dosing regimen - QD

DRUG

Placebo

Placebo, dosage form - capsules, dosing regimen - QD

Trial Locations (1)

NSW 2031

RECRUITING

Scientia Clinical Research, Sydney

All Listed Sponsors
lead

Traws Pharma, Inc.

INDUSTRY